Biocryst Pharmaceuticals buy JPMorgan Chase & Co.
Start price
06.05.25
/
50%
€9.37
Target price
06.05.26
€11.51
Performance (%)
-20.41%
End price
07.05.26
€7.45
Summary
This prediction ended on 07.05.26 with a price of €7.45. The prediction for Biocryst Pharmaceuticals disappointed with a performance of -20.41%. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biocryst Pharmaceuticals | -2.919% | -2.919% | -15.095% |
| iShares Core DAX® | 0.224% | 1.487% | 3.575% |
| iShares Nasdaq 100 | 6.047% | 16.188% | 39.144% |
| iShares Nikkei 225® | 5.724% | 11.690% | 50.962% |
| iShares S&P 500 | 2.172% | 8.056% | 25.618% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Biocryst Pharmaceuticals diskutieren
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its price target raised by analysts at JPMorgan Chase & Co. from $10.00 to $13.00. They now have an "overweight" rating on the stock.
Ratings data for BCRX provided by MarketBeat
In the thread Trading Biocryst Pharmaceuticals
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten
Stopped prediction by JPMorgan_Chase___Co_ for Biocryst Pharmaceuticals
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€4.86
20.11.23
20.11.23
€9.15
20.11.24
20.11.24
44.15%
21.11.24
21.11.24
